HomeNewsQuality / GMP

Lupin gets EIR from US FDA for its Ankleshwar facility

Lupin gets EIR from US FDA for its Ankleshwar facility

Lupin has received the Establishment Inspection Report (EIR) from the United States Food and DLupin gets EIR from US FDA for its Ankleshwar facilityrug Administration (US FDA) for its Ankleshwar manufacturing facility, located in Gujarat, India. The inspection of the facility was conducted from August 16-19, 2022.

Commenting on the development, Nilesh Gupta, Managing Director, Lupin said, “We are happy to have received the EIR for our Ankleshwar facility from US FDA. We remain committed to enhancing compliance and quality standards across all our manufacturing sites.”

Read more on:
EIR Lupin USFDA
More news about: quality / gmp | Published by Sudeep Soparkar | October - 03 - 2022 | 568

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members